DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+31.77%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$232M
AUM Growth
+$232M
(+15%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-14.58%
Top 10 Holdings %
Top 10 Hldgs %
46.06%
Holding
89
New
6
Increased
21
Reduced
20
Closed
10
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$5.54M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$3.1M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$2.39M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$2.16M |
| 5 |
Mersana Therapeutics
MRSN
|
$2.12M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$25.4M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$8.93M |
| 3 |
ADXS
Advaxis, Inc.
ADXS
|
$8.65M |
| 4 |
Ascendis Pharma
ASND
|
$3.87M |
| 5 |
argenx
ARGX
|
$2.83M |
Sector Composition
| 1 | Healthcare | 88.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
76
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| – | – | -228,939 | Closed | -$1.72M |
|
|
NEOS
77
DELISTED
Neos Therapeutics, Inc
NEOS
| – | – | -27,500 | Closed | -$45K |
|
|
VLRX
78
DELISTED
VALERITAS HOLDINGS INC
VLRX
| – | – | -1,325,000 | Closed | -$431K |
|
|
NXTM
79
DELISTED
NxStage Medical Inc.
NXTM
| – | – | -312,119 | Closed | -$8.93M |
|
|
LOXO
80
DELISTED
Loxo Oncology, Inc
LOXO
| – | – | -181,675 | Closed | -$25.4M |
|
81
Incyte
INCY
$16.5B
| – | – | -21,500 | Closed | -$1.37M |
|
82
Leap Therapeutics
LPTX
$12M
| – | – | -170,000 | Closed | -$340K |
|
|
KA
83
DELISTED
Kineta, Inc. Common Stock
KA
| – | – | -54,569 | Closed | -$177K |
|
|
APTX
84
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – | -14,500 | Closed | -$240K |
|
|
CNCE
85
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – | -105,656 | Closed | -$1.33M |
|